Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 31, 2022

Digital rehabilitation platform Neurofenix completes $7 million Series A to transform stroke and brain injury recovery

What does your doctor think about this? Or more importantly does your doctor think about your 100% recovery at all?  Hey it came out in January 2018 so you have an idea how long your doctor has been incompetent. Just looking at this it seems to be for high functioning patients, not me.

"Gameball", which connects to tablet application to make stroke rehabilitation affordable and fun. January 2018 

The latest here:

Digital rehabilitation platform Neurofenix completes $7 million Series A to transform stroke and brain injury recovery

News provided by

Neurofenix

Aug 30, 2022, 09:47 ET


  • Over 75% of stroke, traumatic brain and spinal cord injury patients face long-term disabilities because of insufficient neurorehabilitation and a shortage of occupational therapists
  • Neurofenix's patient-focused approach combines sensor-based technology and telemedicine to personalize rehab and improve recovery
  • Founded in 2016 by Imperial graduates and Entrepreneur First alumni Guillem Singla Buxarrais (CEO) and Dimitrios Athanasiou (CTO)


 

 

 

 

 

 

 

 

ATLANTA, Aug. 30, 2022 /PRNewswire/ -- Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in Series A funding. This funding was led by AlbionVC, with additional participation by HTH, InHealth Ventures, and existing investors. This will enable Neurofenix to build out its product line and invest in US expansion, including funding US clinical trials.  

In the US, where around 795,000 people suffer strokes annually, rehab costs can exceed $17,000 per patient. Neurofenix is the only player in the space providing clinically-validated neuro-rehab combined with patient-centric proprietary technology to enable better patient outcomes. 

Neurofenix's rehab program focuses on arm and hand therapy through its NeuroBall™ platform. Designed with input from over 300 therapists and patients, the tool is personalized to each patient based on their needs and enables them to perform increasingly challenging, repetitive movements to build up strength. The advanced sensors detect the smallest of movements so it can be used by impaired patients, while the wi-fi connected app has activities and digital games to motivate patients to use it regularly. Real-time feedback and leaderboards encourage them to continue. In three separate trials carried out at Brunel University London between 2017 and 2021, patients achieved 20x more movement repetitions at home compared to other methods and the portable platform can be taken anywhere.

The proprietary portal enables remote patient monitoring, proving popular in the US with occupational therapists who increased trust in digital care delivery during Covid-19. 

Guillem Singla Buxarrais, CEO and Co-Founder, Neurofenix, said: "Over the last six years, we have been developing our patient-centric sensor-based technology and platform to transform neuro-rehab. This has proven transformative as previously patients would not have access to in-person physical or occupational therapy due to insurance, financial, transportation and health barriers." 

www.neurofenix.com

No comments:

Post a Comment